Founders Fund

Ataraxis is an AI-based diagnostic platform that helps develop personalized treatment plans.

9amHealth is a healthcare service provider that aims to deliver comprehensive medical support for chronic conditions such as diabetes, hypertension, and hyperlipidemia. The company offers personalized care plans, prescription medication, at-home lab tests, and unlimited virtual visits, ensuring that patients have direct access to affordable and compassionate care. By redesigning all care elements into a single digital service, 9amHealth caters to the modern realities of patients' lives, making healthcare always available and convenient, even for those without insurance. Its focus on chronic conditions highlights its commitment to improving the health and well-being of customers in the United States.

Ostro is a health platform that specializes in personalized engagement solutions for the life sciences sector. Established in 2019 and headquartered in Miami, Florida, Ostro connects the creators of medicines with their users, enhancing healthcare journeys for both consumers and healthcare professionals. The platform facilitates a streamlined patient experience by integrating virtual consultations, logistics, regulatory compliance, and payment services. Through its innovative approach, Ostro aims to improve health outcomes by fostering informed connections and driving engagement, ultimately benefiting patients and life sciences brands alike.

9amHealth is a healthcare service provider that aims to deliver comprehensive medical support for chronic conditions such as diabetes, hypertension, and hyperlipidemia. The company offers personalized care plans, prescription medication, at-home lab tests, and unlimited virtual visits, ensuring that patients have direct access to affordable and compassionate care. By redesigning all care elements into a single digital service, 9amHealth caters to the modern realities of patients' lives, making healthcare always available and convenient, even for those without insurance. Its focus on chronic conditions highlights its commitment to improving the health and well-being of customers in the United States.

COR helps you implement globally-proven healthy lifestyle practices, then shows you a totally new type of data about how your body responds. Optimize your lifestyle and discover the impact of different daily customs with precise, science-based self-knowledge.

9amHealth is a healthcare service provider that aims to deliver comprehensive medical support for chronic conditions such as diabetes, hypertension, and hyperlipidemia. The company offers personalized care plans, prescription medication, at-home lab tests, and unlimited virtual visits, ensuring that patients have direct access to affordable and compassionate care. By redesigning all care elements into a single digital service, 9amHealth caters to the modern realities of patients' lives, making healthcare always available and convenient, even for those without insurance. Its focus on chronic conditions highlights its commitment to improving the health and well-being of customers in the United States.

Calibrate Health, Inc., established in 2020 and based in New York, specializes in digital metabolic health services. It offers a virtual program for sustainable weight loss, combining FDA-approved metabolic medications, a holistic curriculum, and one-on-one virtual coaching. The company's approach, designed by leading obesity and nutrition experts, targets the root causes of weight issues, aiming to improve metabolic health and drive lasting behavior change.

Maximus is a consumer telemedicine company for men’s health and hormone optimization. Maximus is revolutionizing the performance enhancement space by democratizing doctor-prescribed protocols developed by some of the world’s leading experts in men’s health. Maximus’ King Protocol utilizes a convenient prescription medication capsule to stimulate natural testosterone production, proven by at-home lab tests. Maximus was established in 2020 by Cameron Sepah in Santa Monica, California.

Clearing is a digital healthcare platform built to serve the more than 50M chronic pain sufferers in the United States. In partnership with leading physicians and researchers at Harvard, Johns Hopkins, and the Hospital for Special Surgery, and with significant funding from top-tier investors Bessemer Venture Partners, Founders Fund, Breyer Capital, and a host of leading healthcare and consumer entrepreneurs (including the founders of Hims, Seamless Grubhub, Flatiron Health, Forward Health, Curology and more) we are on a mission to provide patients with access to comprehensive, opioid-free pain relief.

Seed Health is a biotechnology company focused on advancing health through innovative applications of microbial sciences. The company develops health supplements that combine probiotics and prebiotics, targeting various aspects of well-being, including digestive health, skin health, heart health, and micronutrient synthesis. By collaborating with academic researchers, Seed Health aims to bring breakthrough discoveries to market, offering consumers live biotherapeutics designed to enhance both human and environmental health.

Seed Health is a biotechnology company focused on advancing health through innovative applications of microbial sciences. The company develops health supplements that combine probiotics and prebiotics, targeting various aspects of well-being, including digestive health, skin health, heart health, and micronutrient synthesis. By collaborating with academic researchers, Seed Health aims to bring breakthrough discoveries to market, offering consumers live biotherapeutics designed to enhance both human and environmental health.

Ostro is a health platform that specializes in personalized engagement solutions for the life sciences sector. Established in 2019 and headquartered in Miami, Florida, Ostro connects the creators of medicines with their users, enhancing healthcare journeys for both consumers and healthcare professionals. The platform facilitates a streamlined patient experience by integrating virtual consultations, logistics, regulatory compliance, and payment services. Through its innovative approach, Ostro aims to improve health outcomes by fostering informed connections and driving engagement, ultimately benefiting patients and life sciences brands alike.

Sana Health, Inc. is a digital health company specializing in a bio-therapeutic device aimed at fostering relaxation to alleviate pain and tension. The company has developed a non-addictive mask and headphone system that employs audio-visual stimulation to enhance the balance between the brain's left and right hemispheres, facilitating a deep state of meditation. This innovative device uses coordinated pulses of light and sound to guide users into a restorative state, thereby improving mental well-being and addressing chronic pain and insomnia. In addition to the hardware, Sana Health offers a mobile application available on both the App Store and Google Play, allowing users to access its features conveniently. Founded in 2015 and headquartered in Lafayette, Colorado, with an additional office in Mill Valley, California, Sana Health is involved in pivotal studies concerning its technology's applications for conditions such as fibromyalgia and neuropathic pain, as well as trials focusing on anxiety and PTSD.

Flo Health, Inc. specializes in developing a women's health application focused on menstruation cycle tracking and reproductive health. Founded in 2015 and based in Redwood City, California, the company offers Flo, an app designed to assist women at various stages of their reproductive lives, including menstruation, conception, pregnancy, early motherhood, and menopause. The Flo app provides features such as personalized health insights, curated cycle and ovulation tracking, and expert tips, all while maintaining a secure and private community for users to discuss their questions and concerns. The application is available in over 20 languages on both iOS and Android platforms, emphasizing safety and reliability as it aims to be a trusted digital resource for women’s health information.

Hims & Hers Health is a multi-specialty telehealth platform that connects consumers with licensed healthcare professionals, facilitating access to high-quality medical care for various conditions, including mental health, sexual health, dermatology, and primary care. Founded in 2017, the company aims to eliminate stigmas associated with health and wellness care, making it easier for individuals to seek necessary treatments. Initially focused on telehealth services for erectile dysfunction and hair loss, Hims & Hers has since expanded its offerings and launched the Hers brand in 2018. To enhance its operations, the company developed its own Electronic Health Record system and partnered with several healthcare providers to facilitate in-person visits with doctors, thus ensuring comprehensive care for its users.

Hims & Hers Health is a multi-specialty telehealth platform that connects consumers with licensed healthcare professionals, facilitating access to high-quality medical care for various conditions, including mental health, sexual health, dermatology, and primary care. Founded in 2017, the company aims to eliminate stigmas associated with health and wellness care, making it easier for individuals to seek necessary treatments. Initially focused on telehealth services for erectile dysfunction and hair loss, Hims & Hers has since expanded its offerings and launched the Hers brand in 2018. To enhance its operations, the company developed its own Electronic Health Record system and partnered with several healthcare providers to facilitate in-person visits with doctors, thus ensuring comprehensive care for its users.

Virta Health Corp. is an online specialty medical clinic dedicated to reversing type 2 diabetes without the use of medications or surgery. Founded in 2014 and based in San Francisco, California, the company utilizes a combination of nutritional biochemistry, clinical expertise, data science, and digital solutions to deliver its innovative treatment. Through its continuous remote care platform, Virta provides extensive medical and behavioral support, which has shown significant results in clinical trials; 60% of enrolled patients achieved diabetes reversal after one year, while 94% of insulin users reduced or eliminated their insulin intake. The benefits of Virta's approach extend beyond diabetes, leading to improvements in blood pressure, inflammation, liver function, and body mass index (BMI), thereby transforming the lives of individuals affected by type 2 diabetes.

Neurotrack Technologies, Inc., established in 2012 and headquartered in Redwood City, California, specializes in digital health solutions for early detection and ongoing monitoring of cognitive impairment, particularly Alzheimer's and other dementias. The company offers a computer-based cognitive test, validated clinically and guided by patients, which can be administered in clinics or at home, fitting various workflows. Neurotrack's proprietary technology has been recognized with 11 patents and is registered as an FDA Class II medical device. The company has published 27 peer-reviewed papers, demonstrating its commitment to scientific rigor and innovation in transforming dementia diagnosis and management.

Counsyl is a health technology company specializing in DNA screening for individuals and families. It aims to enhance health outcomes by providing critical genetic information that can influence behaviors, preventative measures, and overall health preparedness. Operating a modern clinical laboratory, Counsyl has screened over 500,000 patients and collaborated with more than 6,000 health professionals. The company employs advanced technology, including custom robotic automation, to efficiently process blood and saliva samples, allowing for precise analysis of DNA. Counsyl's innovative approach has garnered recognition, including the Wall Street Journal's Innovation Award for Medicine and a spot on Scientific American's list of "Top 10 World Changing Ideas." Its Family Prep Screen has enabled many to uncover vital information before starting families, while its services have expanded to include informed pregnancy and cancer screening.

O.School operates a sexual wellness education platform focused on pleasure education. The platform utilizes live streaming technology and moderated chats to create a shame-free environment where users can learn about sexual health and pleasure. It aims to help individuals unlearn shame, heal from sexual trauma, and develop essential communication skills for expressing their desires and boundaries. O.School fosters an inclusive space that supports diverse sexual identities, allowing users to explore and own their desires without fear of judgment. Through its innovative approach, O.School seeks to empower billions of people on their journey toward enhanced sexual well-being.

Sana Health, Inc. is a digital health company specializing in a bio-therapeutic device aimed at fostering relaxation to alleviate pain and tension. The company has developed a non-addictive mask and headphone system that employs audio-visual stimulation to enhance the balance between the brain's left and right hemispheres, facilitating a deep state of meditation. This innovative device uses coordinated pulses of light and sound to guide users into a restorative state, thereby improving mental well-being and addressing chronic pain and insomnia. In addition to the hardware, Sana Health offers a mobile application available on both the App Store and Google Play, allowing users to access its features conveniently. Founded in 2015 and headquartered in Lafayette, Colorado, with an additional office in Mill Valley, California, Sana Health is involved in pivotal studies concerning its technology's applications for conditions such as fibromyalgia and neuropathic pain, as well as trials focusing on anxiety and PTSD.

Neurotrack Technologies, Inc., established in 2012 and headquartered in Redwood City, California, specializes in digital health solutions for early detection and ongoing monitoring of cognitive impairment, particularly Alzheimer's and other dementias. The company offers a computer-based cognitive test, validated clinically and guided by patients, which can be administered in clinics or at home, fitting various workflows. Neurotrack's proprietary technology has been recognized with 11 patents and is registered as an FDA Class II medical device. The company has published 27 peer-reviewed papers, demonstrating its commitment to scientific rigor and innovation in transforming dementia diagnosis and management.

Genesis Healthcare Co. is a privately-owned genetic testing and research company founded in 2004 and headquartered in Tokyo, Japan, with additional offices in Singapore and Taiwan. The company is recognized as a market leader in consumer genetics in Japan, offering its services under the brand "GeneLife." Genesis Healthcare possesses the largest genetic database in Japan and Asia, encompassing over 988,000 individuals and more than 1,500 diseases. The company utilizes advanced technologies such as PCR, Microarray, and NGS for research and clinically validated genetic testing services. In addition to its commercial offerings, Genesis Healthcare collaborates with government agencies to establish genetic testing guidelines, ensuring accuracy and the protection of individuals' genetic information. By promoting preventive healthcare through genetic testing, Genesis Healthcare aims to enhance public health outcomes across Southeast Asia.

Misfit Wearables, founded in 2011 and headquartered in Burlingame, California, specializes in creating innovative wearable devices aimed at enhancing consumer health and fitness. The company focuses on developing products that encourage users to adopt active lifestyles and cultivate healthy habits. One of its flagship offerings is the Shine, a sleek personal activity tracker that effortlessly syncs with smartphones. As a pioneer in the wearable sensor technology sector, Misfit is dedicated to producing stylish and functional devices that people will want to wear consistently.

Glow, Inc. is a technology company that develops mobile applications and online communities focused on women's health, particularly in areas concerning menstruation, fertility, pregnancy, and menopause. Founded in 2013 and based in San Francisco, Glow offers several applications, including Ruby By Glow, which assists with period and ovulation tracking, and Glow Nurture, designed for pregnancy tracking. The platform provides valuable insights, articles, and tips to support women throughout their reproductive journeys, whether they are trying to conceive, avoiding pregnancy, or coping with miscarriage. Additionally, Glow First is a community program aimed at making infertility treatment more accessible by allowing couples to pool resources and offering financial assistance to those who do not achieve pregnancy through accredited clinics.

Epinomics Inc. specializes in advancing personalized medicine by leveraging big data analytics and proprietary epigenomics technology. Founded in 2013 and located in Menlo Park, California, the company focuses on decoding the human genome to enhance drug development and clinical applications. By utilizing innovative DNA sequencing technology, Epinomics aims to improve existing methodologies in the field, facilitating deeper scientific research and the development of clinical applications. As of March 31, 2018, Epinomics operates as a subsidiary of 10X Genomics, Inc., furthering its mission to revolutionize healthcare through precision medicine.

Misfit Wearables, founded in 2011 and headquartered in Burlingame, California, specializes in creating innovative wearable devices aimed at enhancing consumer health and fitness. The company focuses on developing products that encourage users to adopt active lifestyles and cultivate healthy habits. One of its flagship offerings is the Shine, a sleek personal activity tracker that effortlessly syncs with smartphones. As a pioneer in the wearable sensor technology sector, Misfit is dedicated to producing stylish and functional devices that people will want to wear consistently.

Neurotrack Technologies, Inc., established in 2012 and headquartered in Redwood City, California, specializes in digital health solutions for early detection and ongoing monitoring of cognitive impairment, particularly Alzheimer's and other dementias. The company offers a computer-based cognitive test, validated clinically and guided by patients, which can be administered in clinics or at home, fitting various workflows. Neurotrack's proprietary technology has been recognized with 11 patents and is registered as an FDA Class II medical device. The company has published 27 peer-reviewed papers, demonstrating its commitment to scientific rigor and innovation in transforming dementia diagnosis and management.

Glow, Inc. is a technology company that develops mobile applications and online communities focused on women's health, particularly in areas concerning menstruation, fertility, pregnancy, and menopause. Founded in 2013 and based in San Francisco, Glow offers several applications, including Ruby By Glow, which assists with period and ovulation tracking, and Glow Nurture, designed for pregnancy tracking. The platform provides valuable insights, articles, and tips to support women throughout their reproductive journeys, whether they are trying to conceive, avoiding pregnancy, or coping with miscarriage. Additionally, Glow First is a community program aimed at making infertility treatment more accessible by allowing couples to pool resources and offering financial assistance to those who do not achieve pregnancy through accredited clinics.

Misfit Wearables, founded in 2011 and headquartered in Burlingame, California, specializes in creating innovative wearable devices aimed at enhancing consumer health and fitness. The company focuses on developing products that encourage users to adopt active lifestyles and cultivate healthy habits. One of its flagship offerings is the Shine, a sleek personal activity tracker that effortlessly syncs with smartphones. As a pioneer in the wearable sensor technology sector, Misfit is dedicated to producing stylish and functional devices that people will want to wear consistently.

Counsyl is a health technology company specializing in DNA screening for individuals and families. It aims to enhance health outcomes by providing critical genetic information that can influence behaviors, preventative measures, and overall health preparedness. Operating a modern clinical laboratory, Counsyl has screened over 500,000 patients and collaborated with more than 6,000 health professionals. The company employs advanced technology, including custom robotic automation, to efficiently process blood and saliva samples, allowing for precise analysis of DNA. Counsyl's innovative approach has garnered recognition, including the Wall Street Journal's Innovation Award for Medicine and a spot on Scientific American's list of "Top 10 World Changing Ideas." Its Family Prep Screen has enabled many to uncover vital information before starting families, while its services have expanded to include informed pregnancy and cancer screening.

Azumio Inc. is a Palo Alto, California-based developer of health and fitness mobile applications aimed at improving overall human health. Founded in 2011, the company offers a range of applications, including Instant Heart Rate, Fitness Buddy, and the Argus platform. Argus serves as a comprehensive lifestyle service that facilitates activity and diet tracking while fostering a social network centered on health and fitness. The platform integrates various applications, such as Sleep Time and Glucose Buddy, and also connects with third-party wearable devices. Azumio leverages advanced technologies, including AI and deep learning, to enhance food recognition and provide users with valuable insights into their health and wellbeing.

Pathway Genomics Corporation is a clinical laboratory based in San Diego, California, that specializes in genetic testing services for physicians and patients both in the United States and internationally. The company's offerings include tests in liquid biopsy, hereditary cancer, general health and wellness, pharmacogenomics, and carrier screening. These tests assess a range of conditions such as cancer risk, cardiac health, inherited diseases, and responses to nutrition, exercise, and specific medications related to pain management and mental health. Pathway Genomics is accredited by the College of American Pathologists (CAP) and has established strategic partnerships with organizations like Standard Process and Rainbow Genomics. The company was founded in 2008 and continues to focus on advancing genetic testing technologies and services.